Bambusa Rhus

Manufacturer: Uriel Pharmacy Inc.
Effective date: 2024-12-13
Label type: HUMAN OTC DRUG LABEL
Version: 4
Source: full-release
Hydrated at: 2026-06-01 02:29:34

Label at a glance#

ProductBambusa Rhus

Active ingredientGELSEMIUM SEMPERVIRENS ROOT, PSEUDOGNAPHALIUM LUTEOALBUM LEAF, ACONITUM NAPELLUS, BAMBUSA VULGARIS WHOLE, STACHYS OFFICINALIS, MANDRAGORA OFFICINARUM ROOT, TOXICODENDRON PUBESCENS LEAF, ROSMARINUS OFFICINALIS FLOWERING TOP, FORMICA RUFA, BOS TAURUS INTERVERTEBRAL DISC, PENOXSULAM, SILICON DIOXIDE, SILVER, ARNICA MONTANA

Label structure9 sections

Contacts and useful links#

PhoneLabel contact866.642.2858

Label contents#

Full prescribing information#

INDICATIONS & USAGE SECTION

Directions: FOR ORAL USE ONLY.

DOSAGE & ADMINISTRATION SECTION

Dissolve pellets under the tongue 3-4 times daily. Ages 12 and older: 10 pellets. Ages 2-11: 5 pellets. Under age 2: Consult
a doctor.

OTC - ACTIVE INGREDIENT SECTION

Active Ingredients: Gelsemium (Yellow jasmine) 4X, Gnaphalium (Edelweiss) 4X, Aconitum (Monkshood) 6X, Bambusa (Bamboo) 6X, Betonica (Wood betony) 6X, Mandragora (Mandrake) 6X, Rhus tox. (Sumac) 6X, Rosmarinus (Rosemary) 6X, Formica (Red wood ant) 7X, Disci intervert. (Bovine intervertebral discs of the cerv. thor. and lumbar spine) 8X, Granite (Primitive rock containing quartz, feldspar and mica) 10X, Jasper (Semiprecious stone) 12X, Argentum (SIlver) 20X, Arnica 20X

INACTIVE INGREDIENT SECTION

Inactive Ingredient: Sucrose

Prepared using rhythmical processes.

OTC - PURPOSE SECTION

Use: Temporary relief of headache.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF REACH OF CHILDREN.

WARNINGS SECTION

Warnings: Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated. Contains sugar. Diabetics and persons intolerant of sucrose (sugar): Consult a doctor before use. Do not use if allergic to any ingredient. Consult a doctor before use for serious conditions or if conditions worsen or persist. If pregnant or nursing, consult a doctor before use. Do not use if safety seal is broken or missing.

OTC - QUESTIONS SECTION

Questions? Call 866.642.2858
Uriel, East Troy, WI 53120
shopuriel.com Lot:

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Bambusa Rhus Pellets

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
48951-2017-2	Bambusa Rhus	1350 in 1 BOTTLE, GLASS	PELLET	1350		4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
48951-2017	BAMBUSA RHUS PELLET [URIEL PHARMACY INC.]	4	Legacy NDC, 1 package rows	20241215_31320c3a-2ee9-4a0a-b056-c8b12bb5f448.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
ACONITUM NAPELLUS	ACTIVE INGREDIENT	U0NQ8555JD	1
ARNICA MONTANA	ACTIVE INGREDIENT	O80TY208ZW	1
BAMBUSA VULGARIS WHOLE	ACTIVE INGREDIENT	WCD45M1BSK	1
BOS TAURUS INTERVERTEBRAL DISC	ACTIVE INGREDIENT	0A04Z76C13	1
FORMICA RUFA	ACTIVE INGREDIENT	55H0W83JO5	1
GELSEMIUM SEMPERVIRENS ROOT	ACTIVE INGREDIENT	639KR60Q1Q	1
MANDRAGORA OFFICINARUM ROOT	ACTIVE INGREDIENT	I2XCB174VB	1
PENOXSULAM	ACTIVE INGREDIENT	784ELC1SCZ	1
PSEUDOGNAPHALIUM LUTEOALBUM LEAF	ACTIVE INGREDIENT	BGI20Z6M57	1
ROSMARINUS OFFICINALIS FLOWERING TOP	ACTIVE INGREDIENT	8JM482TI79	1
SILICON DIOXIDE	ACTIVE INGREDIENT	ETJ7Z6XBU4	1
SILVER	ACTIVE INGREDIENT	3M4G523W1G	1
STACHYS OFFICINALIS	ACTIVE INGREDIENT	UO9989Y17N	1
TOXICODENDRON PUBESCENS LEAF	ACTIVE INGREDIENT	6IO182RP7A	1
ACONITUM NAPELLUS	ACTIVE MOIETY	U0NQ8555JD	1
ARNICA MONTANA	ACTIVE MOIETY	O80TY208ZW	1
BAMBUSA VULGARIS WHOLE	ACTIVE MOIETY	WCD45M1BSK	1
BOS TAURUS INTERVERTEBRAL DISC	ACTIVE MOIETY	0A04Z76C13	1
COLLOIDAL SILICON DIOXIDE	ACTIVE MOIETY	ETJ7Z6XBU4	1
FORMICA RUFA	ACTIVE MOIETY	55H0W83JO5	1
GELSEMIUM SEMPERVIRENS ROOT	ACTIVE MOIETY	639KR60Q1Q	1
MANDRAGORA OFFICINARUM ROOT	ACTIVE MOIETY	I2XCB174VB	1
PENOXSULAM	ACTIVE MOIETY	784ELC1SCZ	1
PSEUDOGNAPHALIUM LUTEOALBUM LEAF	ACTIVE MOIETY	BGI20Z6M57	1
ROSMARINUS OFFICINALIS FLOWERING TOP	ACTIVE MOIETY	8JM482TI79	1
SILVER	ACTIVE MOIETY	3M4G523W1G	1
STACHYS OFFICINALIS	ACTIVE MOIETY	UO9989Y17N	1
TOXICODENDRON PUBESCENS LEAF	ACTIVE MOIETY	6IO182RP7A	1
SUCROSE	INACTIVE INGREDIENT	C151H8M554	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 16 matching rows.

Bambusa Rhus
SUCROSE
GELSEMIUM SEMPERVIRENS ROOT
PSEUDOGNAPHALIUM LUTEOALBUM LEAF
ACONITUM NAPELLUS
BAMBUSA VULGARIS WHOLE
STACHYS OFFICINALIS
MANDRAGORA OFFICINARUM ROOT
TOXICODENDRON PUBESCENS LEAF
ROSMARINUS OFFICINALIS FLOWERING TOP
FORMICA RUFA
BOS TAURUS INTERVERTEBRAL DISC
PENOXSULAM
SILICON DIOXIDE
SILVER
ARNICA MONTANA

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
48951-2017	48951-2017-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 15 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
SUCROSE	C151H8M554	IACT
GELSEMIUM SEMPERVIRENS ROOT	639KR60Q1Q	ACTIB
PSEUDOGNAPHALIUM LUTEOALBUM LEAF	BGI20Z6M57	ACTIB
ACONITUM NAPELLUS	U0NQ8555JD	ACTIB
BAMBUSA VULGARIS WHOLE	WCD45M1BSK	ACTIB
STACHYS OFFICINALIS	UO9989Y17N	ACTIB
MANDRAGORA OFFICINARUM ROOT	I2XCB174VB	ACTIB
TOXICODENDRON PUBESCENS LEAF	6IO182RP7A	ACTIB
ROSMARINUS OFFICINALIS FLOWERING TOP	8JM482TI79	ACTIB
FORMICA RUFA	55H0W83JO5	ACTIB
BOS TAURUS INTERVERTEBRAL DISC	0A04Z76C13	ACTIB
PENOXSULAM	784ELC1SCZ	ACTIB
SILICON DIOXIDE	ETJ7Z6XBU4	ACTIB
SILVER	3M4G523W1G	ACTIB
ARNICA MONTANA	O80TY208ZW	ACTIB

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 48 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED / ORAL		145 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, COATED PELLETS / ORAL	59.8 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	119.12 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TROCHE / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE / ORAL		3568 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SOLUTION / RECTAL	35.42 %w/v		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS		2000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL		18790 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS	900 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION / ORAL		48209 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, SOLUTION / INTRAVENOUS	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	PASTILLE / ORAL	426 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION, EXTENDED RELEASE / ORAL		5400 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, EMULSION / INTRAVENOUS		970 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SOLUTION / ORAL		42596 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SOLUTION / ORAL		70000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS	9.4 %w/v		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUPPOSITORY / RECTAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	ELIXIR / ORAL		18000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER / ORAL		27768 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS		1 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / SUBLINGUAL	109 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TROCHE / BUCCAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, EXTENDED RELEASE / ORAL	284.54 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CONCENTRATE / ORAL		4800 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTABLE, LIPOSOMAL / INTRAVENOUS		7560 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER, FOR SUSPENSION / ORAL		40017 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, DELAYED RELEASE / ORAL	295.33 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, CHEWABLE / ORAL		7258 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, COATED, EXTENDED RELEASE / ORAL		86 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION / ORAL		31885 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION / SUBCUTANEOUS	47.75 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS		308 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, COATED / ORAL	516.42 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, EXTENDED RELEASE / ORAL		619 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER, FOR SOLUTION / ORAL		38666 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LOZENGE / BUCCAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LOZENGE / TRANSMUCOSAL		1255 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / BUCCAL	109 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / ORAL		4249 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SYRUP / ORAL		46400 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	WAFER / ORAL	155.2 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION/ DROPS / ORAL		3750 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LIQUID / ORAL		37500 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION / INTRAVENOUS		1950 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, DELAYED RELEASE / ORAL		955 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	DROPS / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
292b268c-ba8f-182f-e063-6294a90a3f24			31320c3a-2ee9-4a0a-b056-c8b12bb5f448	2024-12-13	Warnings	Exact identifier spl id: 292b268c-ba8f-182f-e063-6294a90a3f24 spl set id: 31320c3a-2ee9-4a0a-b056-c8b12bb5f448

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.